Greco, Olga <br/><br/>
Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.  [electronic resource] 

 -  Cancer gene therapy  Jul 2005 
 - 655-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0929-1903 
<br/><br/><label>Standard No.: </label>10.1038/sj.cgt.7700834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents--pharmacology<br/>Antiviral Agents--therapeutic use<br/>Apoptosis<br/>Brain Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Cisplatin--pharmacology<br/>Combined Modality Therapy<br/>DNA-Binding Proteins--genetics<br/>Doxorubicin--pharmacology<br/>Early Growth Response Protein 1<br/>Ganciclovir--metabolism<br/>Gene Expression Regulation--drug effects<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Glioblastoma--drug therapy<br/>Green Fluorescent Proteins--metabolism<br/>Humans<br/>Immediate-Early Proteins--genetics<br/>Neutrons<br/>Promoter Regions, Genetic<br/>Radiation-Sensitizing Agents--therapeutic use<br/>Response Elements--genetics<br/>Simplexvirus--enzymology<br/>Thymidine Kinase--genetics<br/>Transcription Factors--genetics<br/>Tumor Cells, Cultured<br/>Zinc Fingers